Littérature scientifique sur le sujet « Incidental nonfunctioning endocrine pancreatic tumor »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Incidental nonfunctioning endocrine pancreatic tumor ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Incidental nonfunctioning endocrine pancreatic tumor"
Crippa, Stefano, Stefano Partelli, Giuseppe Zamboni, Aldo Scarpa, Domenico Tamburrino, Claudio Bassi, Paolo Pederzoli et Massimo Falconi. « Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors ». Surgery 155, no 1 (janvier 2014) : 145–53. http://dx.doi.org/10.1016/j.surg.2013.08.002.
Texte intégralKim, Daejin, Hanjun Ryu, Hyunsoo Kim, Changkeun Park, Jaekwon Jung, Yunjin Chung, Youngdai Choi et Woo Jae Lee. « Visible Pancreatic Neuroendocrine Tumor after Water Intake and Position Change ». Clinical Ultrasound 6, no 2 (30 novembre 2021) : 71–74. http://dx.doi.org/10.18525/cu.2021.6.2.71.
Texte intégralHaynes, Alex B. « Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine Tumors ». Archives of Surgery 146, no 5 (1 mai 2011) : 534. http://dx.doi.org/10.1001/archsurg.2011.102.
Texte intégralYang, Daohui, Dansong Wang, Yijie Qiu, Xiaofan Tian, Dan Zuo, Yi Dong, Wenhui Lou et Wenping Wang. « Incidental nonfunctioning pancreatic neuroendocrine tumors : Contrast enhanced ultrasound features in diagnosis1 ». Clinical Hemorheology and Microcirculation 80, no 4 (6 avril 2022) : 343–52. http://dx.doi.org/10.3233/ch-211269.
Texte intégralBettini, Rossella, Stefano Partelli, Letizia Boninsegna, Paola Capelli, Stefano Crippa, Paolo Pederzoli, Aldo Scarpa et Massimo Falconi. « Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor ». Surgery 150, no 1 (juillet 2011) : 75–82. http://dx.doi.org/10.1016/j.surg.2011.02.022.
Texte intégralPowell, Anathea C., Cristina H. Hajdu, Alec J. Megibow et Peter Shamamian. « Nonfunctioning Pancreatic Endocrine Neoplasm Presenting as Asymptomatic, Isolated Pancreatic Duct Stricture : A Case Report and Review of the Literature ». American Surgeon 74, no 2 (février 2008) : 168–71. http://dx.doi.org/10.1177/000313480807400217.
Texte intégralYamaguchi, Tetsuya, Hiroshi Takahashi, Ryuzaburo Kagawa, Ryoji Takeda, Shingo Sakata, Michihiro Yamamoto et Yoko Iwasa. « Nonfunctioning Pancreatic Endocrine Tumor Presenting with Hemorrhage from Isolated Gastric Varices ». American Surgeon 71, no 12 (décembre 2005) : 1027–30. http://dx.doi.org/10.1177/000313480507101208.
Texte intégralToshikuni, Nobuyuki, Kyohei Kai et Masayoshi Fujisawa. « Nonfunctioning endocrine pancreatic tumor examined with 18F-FDG PET/CT ». Annals of Nuclear Medicine 22, no 2 (février 2008) : 133–37. http://dx.doi.org/10.1007/s12149-007-0085-0.
Texte intégralFURUTANI, Yuichiro, Takuro TERADA, Syusei SANO, Yoshinori MUNEMOTO, Yosiro IIDA et Takeshi MITSUI. « A Case of Nonfunctioning Pancreatic Endocrine Tumor Presented with Acute Pancreatitis ». Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 77, no 7 (2016) : 1784–90. http://dx.doi.org/10.3919/jjsa.77.1784.
Texte intégralYazawa, Naoki, Toshihide Imaizumi, Ken-Ichi Okada, Masahiro Matsuyama, Shoichi Dowaki, Kosuke Tobita, Yasuo Ohtani, Kyoji Ogoshi, Kenichi Hirabayashi et Hiroyasu Makuuchi. « Nonfunctioning pancreatic endocrine tumor with extension into the main pancreatic duct : Report of a case ». Surgery Today 41, no 5 (mai 2011) : 737–40. http://dx.doi.org/10.1007/s00595-009-4321-1.
Texte intégralThèses sur le sujet "Incidental nonfunctioning endocrine pancreatic tumor"
BONINSEGNA, Letizia. « Incidental nonfunctioning pancreatic endocrine tumors : clinical and surgical implications ». Doctoral thesis, 2012. http://hdl.handle.net/11562/394335.
Texte intégralIntroduction: the widespread use of imaging techniques allowed increasing incidentally detection of asymptomatic non-functioning PNETs (NF-PNETs). Incidental non-functioning PNETs (I-NF-PETs) are usually smaller and lower in stage than symptomatic NF-PNETs (S-NF-PETs) and incidental detection seems to be an important favourable prognostic factor even after accounting for tumor stage, grade and location. There is a complete lack of data as regards of the admitted correct management of asymptomatic patients with potentially benign NF-PET. Aims:1) to define the biological behaviour of I-NF-PETs who underwent surgical resection and 2) to evaluate a follow-up policy in the management of I-NF-PNETs at stage I. Methods: All patients with a pathologically confirmed diagnosis of sporadic NF-PETs who underwent resection at the Departments of Surgery of the University of Verona and of Ospedale “Sacro Cuore – Don Calabria” of Negrar between 1990 and 2011 were included. A comparison of demographic, clinical and pathological characteristics between I-NF-PETs and S-NF-PETs was made. Statistical analyses were performed to identify differences in biological behavior between I-NF-PETs and S-NF-PETs. Results: A total of 131 patients (42.8%) had diagnosis of I-NF-PETs and the remaining 175 patients (57.2%) had diagnosis of S-NF-PETs. No sex predilection was observed (p=0.752). The median patient age was for male: 62 years (range 24 – 83) and 55 (range 17 – 78) with I-NF-PET and S-NF-PET diagnosis respectively; for female was 55 years (range 35 – 72) and 53 (range 25 – 74) with I-NF-PET and S-NF-PET (p= 0.223) respectively. The most common location of I-NF-PETs was in the body-tail of the pancreas (65 cases, 49.6%), whereas S-NF-PETs were most commonly founding both in the body-tail (56.6%) and in the head of the pancreas (38.3%) (p= <0.001). Clear surgical margins (R0) were obtained in 123 patients (93.9%) with I-NF-PET and in 131 patients (74.9%) with S-NF-PET (p<0.001). Median tumor size was lesser for I-NF-PETs with a median of 20 mm (range 7 – 120), than S-NF-PETs (median 35 mm; range 5 – 140); p= 0.016). Therefore T1 incidental tumors were mostly found than symptomatic PETs (p<0.001). Equally lymph-node metastases (N1) were identified in 44.6% of patients with S-NF-PET (78 cases) versus a 20.6% of patients with incidental tumor (27 cases); p<0.001. One patient with I-NF-PET on stage I was found to have malignant disease; this patient initially was classified as benign and underwent enucleation with clear surgical margins (R0), but had liver disease recurrence after 28 months after surgical resection. In this case preoperative imaging evaluation demonstraded the main pancreatic duct (MPD) obstruction (> 5 mm) and a serotonin immunoreactivity at the immunohistochemical evaluation. From September 2007 to September 2011 a total of 19 patients with I-NF-PNET diagnosis were enrolled. All cases was classified as NET-G1 and median size was 15 mm (range 9 – 20). In all cases, no MPD obstruction was confirmed at preoperative imaging. All this patients refused surgical resection. Currently Follow-Up was available for all patients, with a median follow-up of 22 months (range 6 – 48). All Patients were alive, asymptomatic and with tumor stable in size and no evidence of progression disease. Conclusions: this study shows that patients with incidentally detected NF-PETs represent about 40% of resectable NF-PETs and frequency of incidental diagnosis was increasing in last years. Incidental detection seems to be an important favorable prognostic factor for histopathological features, patients overall survival and disease free survival. Anyway pancreatic surgery have a recognized high rate of perioperative morbidities and for < 20 mm and carefully selected pancreatic neuroendocrine “incidentalomas” a clinical-laboratory and radiographic surveillance might be possible.